HOME >> BIOLOGY >> NEWS
Powerful ally in life sciences: UH research head to give keynote

HOUSTON, Feb. 6, 2007 Calling the University of Houston 'a powerful ally to the life science industry in our region,' BioHouston is featuring UH's new head of research, Donald L. Birx, as keynote speaker at its next breakfast forum Wednesday, Feb. 14.

BioHouston, a 501(c)(3) founded by regional academic and research institutions, is establishing the Houston region as a global competitor in life science and biotechnology commercialization and technology transfer to generate economic wealth for the area.

With nearly $75 million in annual research expenditures, researchers at UH collaborate with other Texas Medical Center institutions and regional biotechnology companies. Birx, vice chancellor for the UH System and vice president for research for UH, advocates collaborative strategic activities and research clusters that relate to and translate UH's research capabilities, as well as build on the strengths of the university and its community partners.

In his BioHouston talk 'Research Clusters and Industry Partnerships' Birx will outline the cutting-edge plans he has brought to Houston and the research under way at UH. In his address, he plans to cover how his 'clusters' approach translates to interdisciplinary research, UH's push for Tier I status, how his background in applied research and making marketable applications speaks to the areas of tech transfer and IP, and how his finance background enhances his role in managing scientific research endeavors. He also will elaborate on some of the particular cross-disciplinary research areas he sees as being especially dynamic at UH.

Birx holds a Ph.D. in electrical engineering from the University of Dayton, an M.B.A. in finance and M.S. in biophysics from Miami University in Ohio, and a B.S. in engineering physics from the University of California, Berkeley.

Prior to joining UH in 2006, Birx spent a decade at New Mexico State University (NMSU) in Las Cruce
'"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
6-Feb-2007


Page: 1 2

Related biology news :

1. Quantum biology -- Powerful computer models reveal key biological mechanism
2. Powerful genome ID method extended to humans
3. Powerful technique for multiplying adult stem cells may aid therapies
4. Powerful X-ray beams at Argonne, new electronic flight simulator
5. Powerful toolkit developed for functional profiling of yeast genes
6. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
7. Saudi Arabias KAUST names WHOI first research partner
8. Multinational research: protecting ecology means understanding people, too
9. Newly created cancer stem cells could aid breast cancer research
10. Carnegie Mellons Peter Adams receives EPA research grant
11. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Powerful ally life sciences research head give keynote

(Date:8/26/2015)... The report "Multi-Factor Authentication (MFA) Market ... (Travel & Immigration, Government, Banking, Defense, Commercial Security, Consumer ... published by MarketsandMarkets, Multi-Factor Authentication Market is expected to ... CAGR of 17.7% between 2015 and 2020. ... spread through 169 P ages and ...
(Date:8/24/2015)... CAPE TOWN, South Africa , August 24, 2015 /PRNewswire/ ... awarded Germany ,s largest biometrics manufacturer DERMALOG ... with the "2015 African Biometrics Company of the ... installation in Nigeria .   ... ) and http://www.presseportal.de/nr/8896 - On Thursday ...
(Date:8/20/2015)... Aug. 20, 2015 The wearable technology ... are active and healthy. However, wearable technology has ... environment to help improve diagnostic capabilities and therapeutic ... the Wearable Technologies Conference 2015 , where ... for wearables in healthcare.    "Over ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
(Date:8/26/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended June 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Oral Amp B program, rapidly advancing towards the ... Rae , President & CEO of iCo Therapeutics. "We ...
(Date:8/26/2015)... ... August 26, 2015 , ... Lee Biosolutions, a global ... and manufacture of highly valued cardiac markers used in early detection of heart ... protein chemistry has led to the development and commercialization of important cardiac biomarkers ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
(Date:8/26/2015)... and BEIJING , August 26, 2015 ... Scene with Impressive Acheivements  DiaCardio wins 1 st ... The competition, led in Israel ... featured 21 startups from countries including the US, China ... and Latin America .  Impressive ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6
Cached News: